综述: 胞外囊泡表面糖缀合物研究进展

胞外囊泡(extracellular vesicles,EVs)是一类由细胞分泌到胞外的能够被受体细胞摄取的膜性囊泡小体,直径在20～ 1 000 nm．近年来,越来越多的研究者发现胞外囊泡在疾病诊断、预后评估以及药物递送等方面具有重要的生物学作用．胞外囊泡可以直接参与细胞间信息的传递以及物质的运输,其携带的核酸(mRNA,microRNA和lncRNA)和蛋白质可以影响受体细胞的生理状态．大量研究表明,胞外囊泡是被糖基化修饰的,胞外囊泡表面覆盖了大量的聚糖以及糖结合蛋白,而已知聚糖类物质在调控细胞黏附、细胞-细胞之间的信息传递、细胞和细胞外基质相互作用、免疫调节和肿瘤转移等方面发挥重要的作用．本文综述了近年来细胞外囊泡表面糖缀合物修饰的前沿研究,以期更好地理解聚糖在胞外囊泡的合成、释放以及运输过程及其生物学功能中的作用．     

细胞外囊泡与肿瘤

细胞分泌的胞外囊泡(包括外泌体、微囊泡、凋亡小体、迁移体、retractosomes、R-EVs等)含有DNA、RNA、分泌性蛋白质、脂质、膜受体和其他类型的生物活性大分子。它在细胞的可塑性、细胞间交流和微环境重塑中起着关键作用。该文总结了细胞外囊泡的类型、形成、调节及其在肿瘤发生、转移、肿瘤免疫和靶向治疗中的作用和临床意义。     

运动调控胞外囊泡生物发生的研究进展

胞外囊泡(extracellular vesicles, EVs)是一类由细胞释放的各种具有膜性结构的囊泡的统称,其能被大多数细胞所分泌,通过携带核酸、蛋白质、脂质等特定的生物活性分子到达靶细胞实现细胞间信息交流。目前EV的生物发生调节已成为疾病防治的关键靶点,受到广泛关注。运动能够促进EV的释放,调节其内容物构成,上述作用甚至被认为是机体对运动产生适应的标志。运动时信号通路(如Ca²⁺、mTOR、STAT3等)的激活,细胞微环境(如pH和氧浓度等)乃至EV生物发生相关蛋白质翻译后修饰的变化都会影响EV的形成、内容物分选及囊泡运输等过程。该综述总结了EV的生物发生过程、运动对EV生物发生的影响,并根据现有研究,从信号通路、细胞微环境及蛋白质翻译后修饰的角度分析运动调节EV生物发生的可能机制。     

几种哺乳动物精子顶体膜囊泡形成的研究

在猪、绵羊、地鼠这几种哺乳动物的精子体外获能后,在顶体反应的超显微结构中观察到:精子顶体膜囊泡化呈现多种形态,但囊泡都是由精子顶体的双层外膜多位点自我融合而形成的,质膜并不参与囊泡化,这一结果与前人报道的不同。     

综述与专论: 基于核酸适配体的细胞外囊泡分离分析方法

细胞外囊泡通过参与细胞间通讯，在诸多生理病理过程中发挥着重要作用。因此，细胞外囊泡的分离分析对理解其生物学功能以及发展基于囊泡的疾病诊疗方法具有重要价值。细胞外囊泡的高效分离以及高灵敏可靠检测很大程度上取决于识别配体。核酸适配体是一类高效、特异结合其靶标分子的单链寡核苷酸。核酸适配体的易修饰和可程序化设计等特征，使其成为细胞外囊泡分离和分析的理想识别配体。为提高细胞外囊泡的分离效率，研究者们提出多种策略用于提升核酸适配体的亲和力，以及界面与细胞外囊泡的接触几率。此外，分离不同亚型的细胞外囊泡有助于理解细胞外囊泡的生物学意义。在细胞外囊泡分析方面，根据核酸适配体与细胞外囊泡识别信号的转导方式不同，分为电化学、可视化、表面增强拉曼光谱、荧光法等方法。本文综述了核酸适配体的筛选以及其在细胞外囊泡分离和分析中的最新进展、挑战及未来方向。     

胞外和胞内菌胞外囊泡的功能及应用

细胞外囊泡(Extracellular Vesicles,EVs)是从细胞膜上脱落或者分泌的双层膜结构的囊泡状小体.真核生物、细菌、古细菌和支原体等具有细胞结构的生物均能够释放EVs.细菌分泌的EVs含有DNA、RNA及蛋白质等多种成分,其在细菌毒力保持、免疫逃逸、细菌间物质运输、宿主细胞免疫调节、宿主转录基因调节、耐...     

间充质干细胞及其来源的胞外囊泡

间充质干细胞(MSCs)是一类多组织来源的成体干细胞，具有自我更新及多项分化潜能。移植后，MSCs可以迁移归巢至受损组织，通过分泌免疫调节因子，细胞因子，生长因子，胞外囊泡和其他生物活性物质，发挥抗炎，抗病毒，抗凋亡，抗纤维化，促进血管新生和免疫调节等作用，在治疗自身免疫性疾病及组织器官修复中表现出较好的疗效。目前，国际上已有10余款MSCs产品上市，我国也有30余款间充质干细胞新药获得临床试验默许。胞外囊泡是来源于膜系统，由细胞分泌的双层脂质颗粒，携带有亲本细胞的生物活性物质，包含蛋白质，脂质，mRNA和细胞因子等，可以将亲本细胞信号传递给受体细胞。间充质干细胞来源的胞外囊泡具有与其来源的间充质干细胞相似的生物学特性。因其体积小，免疫原性低，组织渗透性强，循环半衰期长，稳定性高，使用风险低等优点，近年来，胞外囊泡作为非细胞产品逐渐受到关注。除其本身具有组织发育与功能维持，调节免疫，抗氧化应激和促进再生等作用之外，间充质干细胞及其胞外囊泡还可以作为生物载体递送生物活性物质，发挥抗肿瘤和促进组织修复等作用。本文就间充质干细胞及其胞外囊泡的功能及其作为药物载体的研究进展进行综述。     

基于凋亡小体的药物递送系统研究进展

凋亡小体是一类由凋亡细胞释放的细胞外囊泡,由于具有良好的载药功能以及优异的靶向能力,凋亡小体被认为是一种具有潜力的药物递送载体。本文首先概述了凋亡小体的形成机制,然后总结了近年来基于凋亡小体的药物递送系统的相关研究,包括完整凋亡小体药物递送系统、重组凋亡小体药物递送系统、原位生成的凋亡小体药物递送系统以及类凋亡小体仿生药物递送系统,最后对凋亡小体在药物递送领域所面临的挑战和潜在解决策略进行了展望。     

革兰氏阳性菌细胞外囊泡的研究现状

细胞外囊泡(EVs),也称为膜小泡,是真核细胞和细菌分泌的囊泡状小体.它通过携带蛋白质、DNA、RNA和各种代谢物进行细胞间物质的交流传递.根据内容物的不同发挥不同的生理功能,如传递营养物质、参与免疫反应、治疗癌症等.目前大多数研究专注于真核细胞和革兰氏阴性菌囊泡的探索,而对革兰氏阳性菌中分泌的囊泡研究较少.这篇综述总...     

细胞外囊泡及细胞外囊泡数据库

细胞外囊泡（extracellular vesicle,EV）是由细胞释放到细胞外微环境的膜性囊泡,携带母细胞来源分子,参与机体的生理和病理活动过程,鉴定其组成并研究其功能已成为研究热点。目前,对不同物种、不同组织和不同细胞来源的细胞外囊泡组份的研究,获得了大量的蛋白质、核酸、脂类和其他分子数据。为更好地使用这些数据,已有不同的研究机构建立了相应的数据库,为该领域的研究提供了便利。ExoCarta、Vesiclepedia和Evpedia数据库是目前收录数据比较全面的、最具影响力的细胞外囊泡数据库。本文将介绍这3个数据库的特点和应用,为研究者选择使用胞外囊泡数据库提供参考。     

Quantitative Proteomic Analysis of Seminal Plasma,Sperm Membrane Proteins,and Seminal Extracellular Vesicles Suggests Vesicular Mechanisms Aid in the Removal and Addition of Proteins to the Ram Sperm Membrane

Quantitative proteomic studies are contributing greatly to the understanding of the spermatozoon through the provision of detailed information on the proteins spermatozoa acquire and shed in the acquisition of fertility. Extracellular vesicles (EVs) are thought to aid in the delivery of proteins to spermatozoa in the male reproductive tract. The aim of this study is to isolate, identify and quantify EV proteins isolated from ram seminal plasma. Ram sperm plasma membrane proteins are also isolated using nitrogen cavitation and identified to better understand the interplay of proteins between the sperm membrane and extracellular environment. The categorization of proteins enriched in the EV population according to their function revealed three main groupings: vesicle biogenesis, metabolism, and membrane adhesion and remodeling. The latter group contains many reproduction‐specific proteins that show demonstrable links to sperm fertility. Many of these membrane‐bound proteins show testicular expression and are shed from the sperm surface during epididymal maturation (e.g., testis expressed 101; TEX101 and lymphocyte Antigen 6 Family Member K; LY6K). Their association with seminal EVs suggests that EVs may not only deliver protein cargo to spermatozoa but also assist in the removal of proteins from the sperm membrane.     

Extracellular vesicles in urologic malignancies—Implementations for future cancer care

Extracellular vesicles (EVs), a heterogeneous group of vesicles differing in size and shape, cargo content and function, are membrane‐bound and nano‐sized vesicles that could be released by nearly all variations of cells. EVs have gained considerable attention in the past decades for their functions in modulating intercellular signalling and roles as potential pools for the novel diagnostic and prognostic biomarkers, as well as therapeutic targets in several cancers including urological neoplasms. In general, human and animal cells both can release distinct types of EVs, including exosomes, microvesicles, oncosomes and large oncosomes, and apoptotic bodies, while the content of EVs can be divided into proteins, lipids and nucleic acids. However, the lack of standard methods for isolation and detection platforms rein the widespread usage in clinical applications warranted furthermore investigations in the development of reliable, specific and sensitive isolation techniques. Whether and how the EVs work has become pertinent issues. With the aid of high‐throughput proteomics or genomics methods, a fully understanding of contents contained in EVs from urogenital tumours, beyond all doubt, will improve our ability to identify the complex genomic alterations in the process of cancer and, in turn, contribute to detect potential therapeutic target and then provide personalization strategy for patient.     

肠道菌群来源细胞外囊泡在肝脏疾病中的作用研究进展

细胞外囊泡(extracellular vesicles, EVs)是一类具有脂质双分子层的膜性囊泡,可以被各种类型细胞分泌,是生物体通信的重要介质,参与原核生物和真核生物细胞之间的信号传输。在肠道微生态中,微生物-宿主的双向通信通常不需要细胞直接接触,微生物群来源EVs是这种“跨界”对话的关键参与者。肠-肝轴是连接肠道微生物与肝脏的桥梁,参与包含酒精性脂肪性肝病在内的多种肝脏疾病的发生与发展,近年研究发现肠道菌群来源的EVs在肝脏疾病的进程中具有重要的调控作用。本文概述了肠道菌群来源EVs的研究进展,特别是EVs的产生机制、包裹的内容物、在细菌-宿主互作以及在肝脏疾病中的作用。     

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: A novel therapeutic paradigm

Mesenchymal stem cells (MSCs) have been revealed to hold great potential for the development of new treatment approaches for various diseases. However, the clinical use of these cells is limited due to their tumorigenic effects. The therapeutic benefits of MSCs are largely dependent on paracrine factors including extracellular vesicles (EVs). EVs are nano-sized bilayer membrane structures containing lipids, microRNAs and proteins which play key roles in cell-to-cell communications. Because of their lower immunogenicity, tumorigenicity, and easier management, EVs have emerged as a new promising alternative to whole-cell therapy. Therefore, this paper reviews current preclinical studies on the use of EVs derived from human umbilical cord MSCs (hucMSCs) as a therapeutic approach in treatment of several diseases including neurological, cardiovascular, liver, kidney, and bone diseases as well as the cutaneous wound, inflammatory bowel disease, cancers, infertility, and other disorders.     

细胞外囊泡在治疗膝骨关节炎中的作用与前景

膝骨关节炎（knee osteoarthritis,KOA）是以关节软骨退变为主要病变的退行性疾病。目前，KOA尚无有效治疗药物。细胞外囊泡（extracellular vesicles,EVs）是由细胞释放的脂质双分子层包绕形成的球状膜性囊泡，可在细胞间传递核酸、蛋白质等生物活性分子。与动物来源EVs相比，植物来源EVs因其来源广泛且经济，在药物载体递送研究领域引起广泛关注。通过基因工程等方法改造EVs进行药物递送，可极大提高药物递送效率及其疗效。本文综述了动、植物两种来源的EVs在KOA中的治疗进展，特别聚焦于工程化EVs作为药物递送载体在KOA治疗中的研发现状，旨在为利用EVs治疗KOA提供参考。     

Microglia-derived extracellular vesicles in homeostasis and demyelination/remyelination processes

Microglia (MG) play a crucial role as the predominant myeloid cells in the central nervous system and are commonly activated in multiple sclerosis. They perform essential functions under normal conditions, such as actively surveying the surrounding parenchyma, facilitating synaptic remodeling, engulfing dead cells and debris, and protecting the brain against infectious pathogens and harmful self-proteins. Extracellular vesicles (EVs) are diverse structures enclosed by a lipid bilayer that originate from intracellular endocytic trafficking or the plasma membrane. They are released by cells into the extracellular space and can be found in various bodily fluids. EVs have recently emerged as a communication mechanism between cells, enabling the transfer of functional proteins, lipids, different RNA species, and even fragments of DNA from donor cells. MG act as both source and recipient of EVs. Consequently, MG-derived EVs are involved in regulating synapse development and maintaining homeostasis. These EVs also directly influence astrocytes, significantly increasing the release of inflammatory cytokines like IL-1β, IL-6, and TNF-α, resulting in a robust inflammatory response. Furthermore, EVs derived from inflammatory MG have been found to inhibit remyelination, whereas Evs produced by pro-regenerative MG effectively promote myelin repair. This review aims to provide an overview of the current understanding of MG-derived Evs, their impact on neighboring cells, and the cellular microenvironment in normal conditions and pathological states, specifically focusing on demyelination and remyelination processes.     

Extracellular vesicles in normal pregnancy and pregnancy‐related diseases

Extracellular vesicles (EVs) are nanosized, membranous vesicles released by almost all types of cells. Extracellular vesicles can be classified into distinct subtypes according to their sizes, origins and functions. Extracellular vesicles play important roles in intercellular communication through the transfer of a wide spectrum of bioactive molecules, contributing to the regulation of diverse physiological and pathological processes. Recently, it has been established that EVs mediate foetal‐maternal communication across gestation. Abnormal changes in EVs have been reported to be critically involved in pregnancy‐related diseases. Moreover, EVs have shown great potential to serve as biomarkers for the diagnosis of pregnancy‐related diseases. In this review, we discussed about the roles of EVs in normal pregnancy and how changes in EVs led to complicated pregnancy with an emphasis on their values in predicting and monitoring of pregnancy‐related diseases.     

Extracellular vesicle-mediated regulation of tumor angiogenesis— implications for anti-angiogenesis therapy

Angiogenesis plays an important role in tumour progression. However, anti-angiogenesis therapy of inhibiting pro-angiogenic factors failed to meet expectations in certain types of tumour in clinical trials. Recent studies reveal that tumour-derived extracellular vesicles (EVs) are essential in tumour angiogenesis and anti-angiogenesis drug resistance. This function has most commonly been attributed to EV contents including proteins and non-coding RNAs. Here, we summarize the recent findings of tumour-derived EV contents associated with regulating angiogenesis and illustrate the underlying mechanisms. In addition, the roles of EVs in tumour microenvironmental cells are also illustrated with a focus on how EVs participate in cell-cell communication, contributing to tumour-mediated angiogenesis. It will help offer new perspectives on developing targets of anti-angiogenesis drugs and improve the efficacy of anti-angiogenesis therapies based on tumour-derived EVs.     

Extracellular vesicle‐associated organotropic metastasis

Metastasis refers to the progressive dissemination of primary tumour cells and their colonization of other tissues and is associated with most cancer‐related mortalities. The disproportional and systematic distribution pattern of distant metastasis in different cancers has been well documented, as is termed metastatic organotropism, a process orchestrated by a combination of anatomical, pathophysiological, genetic and biochemical factors. Extracellular vesicles (EVs), nanosized cell‐derived membrane‐bound particles known to mediate intercellular communication, are now considered crucial in organ‐specific metastasis. Here, we review and summarize recent findings regarding EV‐associated organotropic metastasis as well as some of the general mechanisms by which EVs contribute to this important process in cancer and provide a future perspective on this emerging topic. We highlight studies that demonstrate a role of tumour‐derived EVs in organotropic metastasis via pre‐metastatic niche modulation. The bioactive cargo carried by EVs is of diagnostic and prognostic values, and counteracting the functions of such EVs may be a novel therapeutic strategy targeting metastasis. Further investigations are warranted to better understand the functions and mechanisms of EVs in organotropic metastasis and accelerate the relevant clinical translation.